to-BBB's Series B - II Round

to-BBB raised a round of funding on April 25, 2013.

to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs w…

Articles about to-BBB's Series B - II Round: